Form 4 for CRBU Caribou Biosciences, Inc.
Accepted 2022-08-24 00:00:00 ET · period of report 2022-08-22 · accession 0001209191-22-047368 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-24 | 2022-08-22 | CRBU | Fischesser Ryan | VP of Fin, Ctrl | A - Grant | $0.00 | +4,848 | 120.4K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-22 | A | A | 4,848 | $0.00 | 120,366 | D | — | — | (F1) Represents a grant of restricted stock units ("RSUs") that vest in two equal annual installments beginning on August 22, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date. |